188 related articles for article (PubMed ID: 36902006)
41. Cancer-associated fibroblasts promote oral squamous cell carcinoma progression through LOX-mediated matrix stiffness.
Zhang JY; Zhu WW; Wang MY; Zhai RD; Wang Q; Shen WL; Liu LK
J Transl Med; 2021 Dec; 19(1):513. PubMed ID: 34930321
[TBL] [Abstract][Full Text] [Related]
42. Clinical significance of L1CAM expression and its biological role in the progression of oral squamous cell carcinoma.
Kim JH; Lee KW; Ahn DG; Oh KY; Yoon HJ
Oncol Rep; 2023 Apr; 49(4):. PubMed ID: 36825596
[TBL] [Abstract][Full Text] [Related]
43. Exploration of pro-apoptotic effect of Thymoquinone on oral squamous cell carcinoma cells through PI3K/Akt signaling pathway.
Ren X; Luo W
Cell Mol Biol (Noisy-le-grand); 2019 Jan; 65(1):61-64. PubMed ID: 30782296
[TBL] [Abstract][Full Text] [Related]
44. Osteoactivin Promotes Migration of Oral Squamous Cell Carcinomas.
Arosarena OA; Dela Cadena RA; Denny MF; Bryant E; Barr EW; Thorpe R; Safadi FF
J Cell Physiol; 2016 Aug; 231(8):1761-70. PubMed ID: 26636434
[TBL] [Abstract][Full Text] [Related]
45. Autophagy indicators in oral squamous cell carcinoma.
Pangarkar M; Wagh U; Pathak A
Pathology; 2024 Feb; 56(1):59-64. PubMed ID: 37981514
[TBL] [Abstract][Full Text] [Related]
46. Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells.
Zainal NS; Gan CP; Lau BF; Yee PS; Tiong KH; Abdul Rahman ZA; Patel V; Cheong SC
Phytomedicine; 2018 Jan; 39():33-41. PubMed ID: 29433681
[TBL] [Abstract][Full Text] [Related]
47. Knockdown of lncRNA IGF2BP2-AS1 inhibits proliferation and migration of oral squamous cell carcinoma cells via the Wnt/β-catenin pathway.
Tong S; Wang X; Guo X; Lu Z
J Oral Pathol Med; 2022 Mar; 51(3):272-280. PubMed ID: 34637162
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of the PI3K/AKT Pathway Sensitizes Oral Squamous Cell Carcinoma Cells to Anthracycline-Based Chemotherapy In Vitro.
Smolensky D; Rathore K; Bourn J; Cekanova M
J Cell Biochem; 2017 Sep; 118(9):2615-2624. PubMed ID: 27649518
[TBL] [Abstract][Full Text] [Related]
49. Ursolic acid induces apoptosis and autophagy in oral cancer cells.
Lin CW; Chin HK; Lee SL; Chiu CF; Chung JG; Lin ZY; Wu CY; Liu YC; Hsiao YT; Feng CH; Bai LY; Weng JR
Environ Toxicol; 2019 Sep; 34(9):983-991. PubMed ID: 31062913
[TBL] [Abstract][Full Text] [Related]
50. Palbociclib induces DNA damage and inhibits DNA repair to induce cellular senescence and apoptosis in oral squamous cell carcinoma.
Wang TH; Chen CC; Leu YL; Lee YS; Lian JH; Hsieh HL; Chen CY
J Formos Med Assoc; 2021 Sep; 120(9):1695-1705. PubMed ID: 33342707
[TBL] [Abstract][Full Text] [Related]
51. A new link between apoptosis induced by the metformin derivative HL156A and autophagy in oral squamous cell carcinoma.
Nguyen MT; Choe HC; Kim BH; Ahn SG
Eur J Pharmacol; 2022 Apr; 920():174859. PubMed ID: 35219727
[TBL] [Abstract][Full Text] [Related]
52. Extract of Ficus septica modulates apoptosis and migration in human oral squamous cell carcinoma cells.
Bai LY; Wu KL; Chiu CF; Chao HC; Lin WY; Hu JL; Peng BR; Weng JR
Environ Toxicol; 2023 Mar; 38(3):666-675. PubMed ID: 36436203
[TBL] [Abstract][Full Text] [Related]
53. SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma.
Yoon TM; Kim SA; Cho WS; Lee DH; Lee JK; Park YL; Lee KH; Lee JH; Kweon SS; Chung IJ; Lim SC; Joo YE
BMC Cancer; 2015 Nov; 15():888. PubMed ID: 26555193
[TBL] [Abstract][Full Text] [Related]
54. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy.
Huang KJ; Kuo CH; Chen SH; Lin CY; Lee YR
J Cell Mol Med; 2018 Mar; 22(3):1894-1908. PubMed ID: 29363886
[TBL] [Abstract][Full Text] [Related]
55. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
Prgomet Z; Axelsson L; Lindberg P; Andersson T
J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
[TBL] [Abstract][Full Text] [Related]
56. Curcumin analog HO-3867 triggers apoptotic pathways through activating JNK1/2 signalling in human oral squamous cell carcinoma cells.
Chen CW; Hsieh MJ; Ju PC; Hsieh YH; Su CW; Chen YL; Yang SF; Lin CW
J Cell Mol Med; 2022 Apr; 26(8):2273-2284. PubMed ID: 35191177
[TBL] [Abstract][Full Text] [Related]
57. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Kang Y; Zhang Y; Sun Y
Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
[TBL] [Abstract][Full Text] [Related]
58. Combined cetuximab and celecoxib treatment exhibits a synergistic anticancer effect on human oral squamous cell carcinoma in vitro and in vivo.
Qian M; Qian D; Jing H; Li Y; Ma C; Zhou Y
Oncol Rep; 2014 Oct; 32(4):1681-8. PubMed ID: 25328959
[TBL] [Abstract][Full Text] [Related]
59. RNAi-mediated downregulation of oral cancer overexpressed 1 (ORAOV1) inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation.
Zhao X; Liu D; Wang L; Wu R; Zeng X; Dan H; Ji N; Jiang L; Zhou Y; Chen Q
J Oral Pathol Med; 2016 Apr; 45(4):256-61. PubMed ID: 26449957
[TBL] [Abstract][Full Text] [Related]
60. The role of p21-activated kinase 4 in the progression of oral squamous cell carcinoma by targeting PI3K-AKT signaling pathway.
Zhang L; Lin S; Zhang Z; Yan C; Liu F
Clin Transl Oncol; 2023 Mar; 25(3):739-747. PubMed ID: 36593383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]